These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 26711766)

  • 21. Pharmacodynamic comparisons of antimicrobials against nosocomial isolates of escherichia coli, klebsiella pneumoniae, acinetobacter baumannii and pseudomonas aeruginosa from the MYSTIC surveillance program: the OPTAMA Program, South America 2002.
    Kiffer CR; Mendes C; Kuti JL; Nicolau DP
    Diagn Microbiol Infect Dis; 2004 Jun; 49(2):109-16. PubMed ID: 15183860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of resistance of bacteria causing ventilator-associated pneumonia.
    Szabo D; Silveira F; Fujitani S; Paterson DL
    Clin Chest Med; 2005 Mar; 26(1):75-9. PubMed ID: 15802168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventing antibiotic resistance by switching off its activity.
    Heinzelmann E
    Chimia (Aarau); 2014; 68(4):269-70. PubMed ID: 24983613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogens resistant to antibacterial agents.
    Chen LF; Chopra T; Kaye KS
    Infect Dis Clin North Am; 2009 Dec; 23(4):817-45, vii. PubMed ID: 19909886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Colistin: an update on the antibiotic of the 21st century.
    Biswas S; Brunel JM; Dubus JC; Reynaud-Gaubert M; Rolain JM
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):917-34. PubMed ID: 23030331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
    Finch R; Hunter PA
    J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Overview perspective of bacterial resistance.
    Furtado GH; Nicolau DP
    Expert Opin Ther Pat; 2010 Oct; 20(10):1273-6. PubMed ID: 20687782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period].
    Asencio MÁ; Huertas M; Carranza R; Franco M; Castellanos J; Barberá JR; Conde Mdel C; Tenías JM
    Rev Esp Quimioter; 2014 Dec; 27(4):261-8. PubMed ID: 25536430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Surveillance of antimicrobial resistance among nosocomial gram-negative pathogens from 15 teaching hospitals in China in 2005].
    Yang QW; Xu YC; Chen MJ; Hu YJ; Ni YX; Sun JY; Yu YS; Kong HS; He L; Wu WY; Ye HF; Yang YM; Zhu LN; Guo SH; Ji P; Zhu ZH; Ren JK; Zhang LX; Sun ZY; Zhu XH; Tong MQ; Zhao WS; Mei YN; Liu Y; Zhang ZJ; Duan Q; Li D; Liu PP; Wang J; Han LX; Wang H; Xie XL
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2753-8. PubMed ID: 18167265
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell-wall-inhibiting antibiotic combinations with activity against multidrug-resistant Klebsiella pneumoniae and Escherichia coli.
    Hickman RA; Hughes D; Cars T; Malmberg C; Cars O
    Clin Microbiol Infect; 2014 Apr; 20(4):O267-73. PubMed ID: 24118201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of topical antimicrobial agents against multidrug-resistant bacteria recovered from burn patients.
    Glasser JS; Guymon CH; Mende K; Wolf SE; Hospenthal DR; Murray CK
    Burns; 2010 Dec; 36(8):1172-84. PubMed ID: 20542641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investigation of antibiotic resistance in the genomic era of multidrug-resistant Gram-negative bacilli, especially Enterobacteriaceae, Pseudomonas and Acinetobacter.
    Diene SM; Rolain JM
    Expert Rev Anti Infect Ther; 2013 Mar; 11(3):277-96. PubMed ID: 23458768
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microbiological surveillance and antimicrobial stewardship minimise the need for ultrabroad-spectrum combination therapy for treatment of nosocomial infections in a trauma intensive care unit: an audit of an evidence-based empiric antimicrobial policy.
    Ramsamy Y; Muckart DJ; Han KS
    S Afr Med J; 2013 Mar; 103(6):371-6. PubMed ID: 23725954
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bacteria isolated from surgical infections and their susceptibilities to antimicrobial agents: special references to bacteria isolated between July 1996 and June 1997].
    Mashita K; Shinagawa N; Ishikawa S; Hirata K; Denno R; Mukaiya M; Mizuno A; Ishibiki K; Ushijima Y; Kinoshita H; Morimoto K; Aikawa N; Yamazaki M; Fujimoto M; Iwai S; Kato K; Tanimura H; Ohnishi H; Maeda T; Sato T; Tanaka N; Inoue F; Iwagaki H; Yura J; Tanaka S
    Jpn J Antibiot; 1999 May; 52(5):398-430. PubMed ID: 10480049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria.
    Fadli M; Chevalier J; Saad A; Mezrioui NE; Hassani L; Pages JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):325-30. PubMed ID: 21752605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic Resistance: The Need For a Global Strategy.
    Elder DP; Kuentz M; Holm R
    J Pharm Sci; 2016 Aug; 105(8):2278-87. PubMed ID: 27397433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence and antimicrobial resistance among Gram-negative pathogens in Saudi Arabia.
    Yezli S; Shibl AM; Livermore DM; Memish ZA
    J Chemother; 2014 Oct; 26(5):257-72. PubMed ID: 24669827
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of antibacterial efficacy of phyto fabricated silver nanoparticles using Mukia scabrella (Musumusukkai) against drug resistance nosocomial gram negative bacterial pathogens.
    Prabakar K; Sivalingam P; Mohamed Rabeek SI; Muthuselvam M; Devarajan N; Arjunan A; Karthick R; Suresh MM; Wembonyama JP
    Colloids Surf B Biointerfaces; 2013 Apr; 104():282-8. PubMed ID: 23334182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.